Vectura is a FTSE 250, industry-leading device & formulation business for inhaled airways disease.
Horizon Discovery is a world-leader in the application of gene editing and is at the centre of innovation and drug discovery.
IBA is a global leader in proton therapy solutions for the treatment of cancer.
Arix Bioscience is a global healthcare and life science company focused on generating value from the commercialisation of innovation in healthcare, with a permanent capital structure supporting a long-term investment model.
Immunocore is the world's leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases.
Quanta is a medical device company providing innovative haemodialysis solutions for the clinic and the home.